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NutritionEpidemiological studies propose that extension of the human lifespan or the reduction of age associated
diseases may be achieved by physical exercise, caloric restriction, and by consumption of certain substances
such as resveratrol, selenium, ﬂavonoids, zinc, omega 3 unsaturated fatty acids, vitamins E and C, Ginkgo biloba
extracts, aspirin, green tea catechins, antioxidants in general, and even by light caffeine or alcohol
consumption. Though intriguing, these studies only show correlative (not causative) effects between the
application of the particular substance and longevity. On the other hand, obesity is yet a strong menace to the
western society and itwill emerge evenmore so throughout the next decades according to the prediction of the
WHO. Although obesity is considered a severe problem, very little is known about the molecular mechanisms
causing the associated degeneration of organs and ﬁnally death. Nutrient related adverse consequences for
health and thus ageingmay be due to a high sugar or high fat diet, excessive alcohol consumption and cigarette
smoke amongst others. In this article we examine the interdependencies of eating and ageing and suggest
yeast, one of the most successful ageing models, as an easy tool to elucidate the molecular pathways from
eating to ageing. The conservation of most ageing pathways in yeast and their easy genetic tractability may
provide a chance to discriminate between the correlative and causative effects of nutrition on ageing.).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Epidemiological studies: Correlation or causality?
Epidemiological studies propose that substances or behaviour may
have beneﬁcial effects on longevity (or diseases associatedwith ageing).
These studies suggest that anti-ageing or protection from age associated
disease can be achieved by moving [1], fasting [2] or even consuming
medications or meals that contain: selenium [3,4], zinc [5], ﬂavonoids
[6–9], omega 3 unsaturated fatty acids [10], aspirin [11,12], caffeine
[13,14], resveratrol/procyanidine [15], vitamin C [16,17] or vitamin E
[18,19] (see Table 1). These studies appear to show correlative effects
between the application of a particular substance and longevity that,
though intriguing, may not necessarily be causative. For example
individuals consuming red wine in potentially lifespan prolonging
proportions might also nourish themselves in an overall healthier style
compared to othersmeaning that the positive effects on longevity must
not be associatedwith the consumption of redwine alone. Additionally,
in the special caseof redwine,which contains a very complexmixtureof
polyphenols (including ﬂavonoids like anthocyanins and ﬂavan-3-ols,
and non ﬂavonoids like resveratrol), alcohol and other chemicals, such
as procyanidine could also have signiﬁcant effects on longevity [15]
instead of or in addition to resveratrol [20,21]. This example shows that
epidemiological studies are indeed helpful to get an idea of healthyliving but cannot give a real explanation for the effects on longevity due
to a certain life-style or a single component in nourishment.
Another example is the Ginkgo biloba extract EGb 761, that is
suggested to have positive effects regarding neurodegenerative dis-
orders such as dementia and Alzheimer's disease (AD). The extract
basically consists of ﬂavone glycosides (quercetin, kaempferol, and
isorhamnetin), and terpene lactones (ginkgolides A, B and C, and
bilobalide). Although, no epidemiological studies are available for
G. biloba treatments, a few studies suggestGinkgo extracts to be efﬁcient
in AD treatment [7,22]. However previous study could not reveal the
efﬁcacy of such extracts [23]. Luo et al. demonstrated that G. biloba
extract EGb 761 inhibited amyloid beta aggregation in vitro and that
ROS formation is attenuated in C. elegans [24]. Nevertheless, the
mechanisms of these processes remain unclear. Besides the age-related,
neuro-protective functions ofGinkgo extracts it also provides protection
from ovary cancer development [8], another manifestation of age.
Treatment of humanised yeasts heterologously expressing amyloid beta
with Ginkgo extracts during chronological or replicative ageing may
clarify this hypothesis.
Other studies suggest that the consumption of vegetable matter
and plant derived foods and beverages has positive effects on the
prevention of age associated diseases like coronary heart disease
(CHD) and atherosclerosis as well as for longevity [6,15,17], but the
assignation of effects to discrete substances within this plant food and
the elucidation of molecular mechanisms will be easier starting with
high throughput screens in simple but effectivemodel organisms such
as yeast, nematodes or ﬂies.
Table 1
Substances with proposed effects on humans.
Diet Inﬂuence of ageing in humans References
Positive inﬂuence on ageing
Calorie restriction No life long studies in humans, but trends between low energy intake and reduced risk for all-cause
mortality and absence of many age-related diseases
[2,33]
Light alcohol consumption Reduced myocardial infarction risk, increased insulin sensitivity [34,35]
Flavonoids (vegetable matter) Prevention of age associated disease such as coronary heart disease (CHD) [6,17]
Red wine (resveratrol and procyanidine) Reduces risk for CHD and increases longevity [15]
Green tea catechins Antioxidant properties (anti-ageing), anti-angiogenic, hypocholesterolemic, anti-atherosclerotic, and
protection against Parkinson's- and Alzheimer's diseases (AD) and ischemic damage
[9]
Aloe vera No human supplementation studies, reduced risk for thrombosis and all-cause mortality,
lowers hepatic cholesterol levels and has probably anti-ageing properties as an antioxidant in mice
[36,37]
Spermidine No human supplementation studies, but intracellular concentration declines during human ageing.
Extends lifespan of yeast, ﬂies and worms, and human immune cells via enhancement of autophagy
[38]
Omega 3 unsaturated fatty acids (ﬁsh) Reduced risk of CHD, sudden cardiac death, atherosclerosis and atrial ﬁbrillation for elderly people [10]
Vitamin E Probably reduced risk of CHD, but still controversial [18,19]
Vitamin C Reduced risk for AD and reduced overall mortality (especially from heart disease) [16,17]
Selenium Increased self perceived health, physical activity and quality of life, and probably increases muscle
strength in older women
[3,4]
Zinc Improved immune response, prevention of age-related disease and increased longevity,
and enhances the anti-oxidative defences of peripheral blood lymphocytes
[39,40]
Coffee (caffeine) Reduced myocardial infection risk and reduced risk of AD for humans and Alzheimer's mice [13,14,41]
Ginkgo biloba extracts (quercetin, ginkgolides A and B) Prevention of ovary cancer and anti-proliferative effects and improved cognitive and non-cognitive
symptoms in dementia
[7,8]
Aspirin Reduced total cancer incidence and cancer mortality and reduced risk for coronary heart disease
mortality and all-cause mortality
[11,12]
Adverse effects on ageing
Smoking Accelerates the ageing process, reduced longevity, overall increased mortality, risk for cancer,
cardiovascular and respiratory diseases
[42–44]
High-sugar-diet Hyperglycemia, insulin resistance, and diabetes [45]
High-fat-diet Obese subjects fail to inhibit insulin-mediated glucose disposal due to raised FFA and develop hepatic
insulin resistance, and high fat diet leads to insulin resistance and obesity in rats
[46,47]
Deﬁcit in physical exercise Higher all-cause mortality and reduced longevity [1]
Excessive alcohol consumption Increased risk for CHD, diabetes, and stroke and increased mortality [48–50]
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life forms such as yeast, worms, and ﬂies [25–29], has most recently
been demonstrated to prolong mammalian lifespan as well via mTOR
inhibition [30]. This proves again that simple research organisms such
as yeast, worm and ﬂies may serve as a model for ageing research in
highly developed mammals.
Investigations of age associated effects due to alcohol are probably
hard to construe when performed in the yeast model, since yeast
produces ethanol itself during fermentation and thus, tolerates high
doses. Though recent works suggest that exceeding these high doses
is detrimental and leads to apoptosis in yeast [31,32].2. Healthy ageing: A special diet for yeast
Age-induced cell death may be a cause for ﬁnal organ degener-
ation, and thus overall ageing and death. In order to further
understand ageing processes in higher eukaryotes, including humans,
the exploration of cellular ageing mechanisms will be invaluable
basement work. Importantly, the sirtuins, ubiquitously conserved
ageing regulators, have been identiﬁed originally in a yeast screen
[51].
Apoptosis and necrosis are both very important age-related
cellular features, since dysfunction of programmed cell death (PCD)
mechanisms also leads to severe human diseases such as Alzheimer's
and Parkinson's disease, ischemia, and cancer [52–54]. Oxygen
radicals seem to be key elements of both, ageing as well as apoptotic
execution, conserved during evolution [55,56]. A number of exoge-
nously added substances such as acetic acid [57], sugar [58] or salt-
stress [59,60], plant antifungal peptides [61], or hydrogen peroxide
[55] trigger apoptosis in yeast. Furthermore, numerous players of
apoptotic execution such as the yeast caspase Yca1p [62], Bax
inhibitor BI-1 [63], homologues of HtrA2/Omi (Nma111p) [64], Aif(Aif1p) [65], AMID (Ndi1p) [66], and endonuclease G (Nuc1p) [67]
have been identiﬁed in yeast so far.
Saccharomyces cerevisiae offers two models for lifespan analysis,
the so-called ‘replicative’ and ‘chronological’ models. Yeast's replica-
tive lifespan, or ‘mother cell speciﬁc ageing’, is deﬁned as the number
of divisions an individual cell undergoes before dying [68]. This
experimental setup compares to the ageing process of dividing cells
such as stem cells or ﬁbroblasts. Yeast's chronological lifespan, by
contrast, is the length of time a population remains viable in the post-
diauxic/stationary phase [69]. These chronological ageing studies in
yeast are used as a model for oxidative stress and ageing of
postmitotic tissues in higher eukaryotes. Both replicatively and
chronologically aged yeast cells die exhibiting markers of apoptosis,
such as accumulating oxygen radicals, chromatin condensation, and
caspase activation [69,70]. For a recent review on yeast apoptosis and
ageing see [71].
The composition and alteration of lipid species throughout cellular
ageing is up to now only barely characterised. Research on that ﬁeld
may be a key to understanding age-induced cell death mechanisms.
Questions such as: “Why do organs die due to lipid overload?” might
be answered and even inhibitors of cell deathmight be developed as a
consequence.
Furthermore, substances with a predicted effect on human ageing,
as presented in the introduction, could be easily tested for modifying
yeast ageing. Sincemost ageingmechanisms are conserved from yeast
to human, effects of substances such as listed in Table 1 on yeast
ageing are probable.
Resveratrol has already been tested in yeast replicative ageing,
which led to an increase in lifespan by 70% [21]. It is suggested to
mimic CR by stimulation of Sir2p. However, a chronological ageing
with yeast cells being supplemented with resveratrol is still lacking.
The ﬂavonoid quercetin, by contrast, has been tested in chronological
ageing, resulting in a 60% increase in yeast lifespan following
501P. Rockenfeller, F. Madeo / Biochimica et Biophysica Acta 1803 (2010) 499–506treatment [72]. This result conﬁrms once again that yeast is indeed an
appropriate model for such studies.
Most recently Eisenberg et al. demonstrated that application of
spermidine, a substance most prominent in male sperm liquid,
prolongs yeast lifespan up to three-fold. Furthermore, external
administration of spermidine promotes longevity also in Drosophila,
C. elegans and mammalian cell cultures [38]. Analogous, testing of
further substances such as listed in Table 1might lead to the ﬁnding of
other such spectacular results (Fig. 1).3. Glucotoxicity: Sugar as a trigger for yeast cell death
Elevated blood glucose levels in humans are associated with a
variety of adverse health consequences. First glucose levels increase
into the prediabetic states, which are metabolically abnormal and
thus, ultimately lead to development of type 2 diabetes. Yet, pre-
diabetic individuals show hormonal defects, such as a decrease in
insulin secretion [73–75] and increase in glucagon secretion [76], both
of which potentiate hyperglycaemia. Throughout the development
of diabetes beta cell function becomes constitutively defective and
beta cell mass ﬁrst increases to counteract the need of insulin, but
is then chronically reduced by apoptotic cell death [77]. Furthermore,
endogenous glucose production via gluconeogenesis increases in liver
[78] and kidney [79].Fig. 1. Yeast versus human. Diverse substances inﬂuence human and/or yeast ageing negati
and identiﬁcation of discrete active components.In yeast induction of apoptosis through sugars seems a paradox
when it is considered that yeast relies on glucose as one of its
preferred aliments. Nevertheless, sugar induced cell death could be
demonstrated to occur in S. cerevisiae in the absence of additional
nutrients to support growth [58]. Most recently, this result could be
conﬁrmed in the bottom fermenting yeast Saccharomyces pastorianus,
where sugar induced cell death occurs under anaerobic condi-
tions [80]. Furthermore, Yoshimoto et al. demonstrated that the ratios
of glucose and non-glucose nutrients balance cell death induction.
Granot et al. propose that sugar induced cell death, which is mediated
by production of ROS, does not occur naturally as glucose is normally a
limited resource [58]. Only in an artiﬁcial, high sugar environment
combined with a lack of complementing nutrients is apoptotic death
induced, probably because evolution did not provide yeast with an
appropriate protectionmechanism, as it was unnecessary. Postulating
that these ﬁndings were equivalent in humans an analogous scenario
is imaginable: An artiﬁcial high glucose intake is not a rare event in
the ‘overfed’ western society. Chocolate bars and junk food are far
away from natural occurring sugar amounts. Combined with an
undersupply in vitamins and micronutrients the scenario would be
fulﬁlled: Cell death leading further to organ degeneration or
malfunction would be the result.
Notably, high blood sugar concentrations have deleterious effects
during diabetes mellitus. Advanced glycation endproducts (AGEs) are
a consequence, which are caused by glycation of cellular proteins in avely or positively. Yeast serves as a model for nutrient dependant lifespan investigation
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have been shown to occur also after treatment with Dihydroxyace-
tone (DHA), a substance which is converted into DHA-phosphate, a
metabolite of glycolysis [81]. Therefore, it may be used to artiﬁcially
raise glycation, thereby mimicking a diabetic phenotype.
4. Lipotoxicity: Obese yeast die young
Cell death can also be triggered by anomalous uptake, generation
or the activity of diverse lipid derivatives. The molecular mechanisms
underlying the process of lipotoxicity, which is deﬁned as lipid
mediated adverse effects including deregulation of metabolic path-
ways, cell and organelle dysfunction and cell death, are only poorly
characterised.
Since cell death and ageing are very closely linked, lipid induced
cell death also has to be considered in ageing research. During
chronological yeast ageing Goldberg et al. showed that intracellular
levels of diverse lipid species and lipid metabolism are altered when
cells are grown under CR conditions [82]. This hints to lipids having a
function during ageing and needs further investigation. Furthermore,
lipid species might play a role in the development of neurodegener-
ative disorders, which are known to appear with age.
A number of publications on lipid metabolism and also lipid
induced cell death in yeast are available. Kurat et al. identiﬁed the
triglyceride lipase 4 as a functional ortholog of mammalian adipose
triglyceride lipase giving evidence that lipolysis is conserved from
yeast to mammals [83]. In a second study, they could also
demonstrate that Tgl4 mediated lipolysis is dependent on Cdk1/
Cdc28 and therefore directly linked to the cell-cycle [84]. Pineau et al.
found that an increase in intracellular saturated fatty acids (SFA)
induces the unfolded protein response (UPR) [85]. Furthermore,
ergosterol is shown to act synergistically on this effect, which makes
their experimental setup a model for cell death in obesity and
atherosclerosis. Using a quadruple knock outmutant, which is entirely
blocked in TAG synthesis, Petschnigg et al. showed that supplemen-
tation with oleic acid (OA) leads to massive proliferation of
intracellular membranes, indicating that the cell reacts on impaired
FA-esteriﬁcation with an increase in phospholipid synthesis. [86] This,
in turn, could trigger the UPR, which was, surprisingly, only
moderately induced in this work. Garbarino et al., who used the
identical system to investigate on lipotoxicity could show that yeast
cells challenged with FA undergo cell death, which is accompanied by
increased ROS levels. Additionally, they demonstrate that in the case
of treatment with UFA such as OA the UPR is induced as evidenced by
induction of Ire1p mediated HAC1 m-RNA splicing [87].
Besides FFA, other lipotoxic triggers such as ceramides [88],
cholesterol [89] and diacylglycerol (DAG) [90] are described in the
literature, but not all of them using yeast as a model. Elevated
intracellular concentrations of FFA can lead to the synthesis of
ceramides in lethal doses and ceramides, in turn, can trigger cell death
via different pathways. Still, the downstream executors of ceramide
induced cell death remain largely unknown. Other studies suggest
that FFA trigger apoptosis by ceramide-independent pathways [91,92]
e.g. cytochrome c release [93–96]. Moreover, FFA (but also ceramides)
are known to interfere with several signal transduction pathways
including PKB (Akt) [97,98] causing activation of proapoptotic
members of the Bcl-2 family (BAD). PKCmediated signal transduction
pathways can be activated by DAG [99] which is generated as a lipid
second messenger by hydrolysis of membrane phospholipids. Puta-
tive cell death executors responding to lipid overload are caspases, the
mitochondrial endonuclease G (endoG) and other mitochondrially
located death factors or ROS. It has been suggested that ROS, rather
than ceramide, mediate the palmitate-induced apoptosis in Chinese
hamster ovary cells [91].
Although a few publications indeed describe lipotoxic insults,
the effects of lipid species on ageing and how intracellular levels oflipids vary during ageing still remain to be investigated. An overall
screen for lipotoxic substances and their effects on ageing is still
not available but is easily feasible in yeast. Furthermore, the kind
of cell death could be characterised via established methods and
eventually death executors could be identiﬁed by simple knock out
studies.
Additionally to the mentioned lipotoxic effects of some lipids,
others for example polyunsaturated fatty acids may provide anti-
oxidative properties and therefore exhibit protection against ageing.
Several diets propose these healthy fats to replace unhealthier ones
mostly animal derived and unsaturated in the diet. Nevertheless,
polyunsaturated fatty acids are also very susceptible to oxidation,
thus might lead to oxygen stress. A raised consumption of these,
nowadays very popular, supplements should be critically reviewed in
our opinion.
5. Calorie restriction in yeast
By reducing an organism's energy intake, i.e. Calorie Restriction
(CR), an extension in longevity could be observed in every organism
tested to date [100,101]. Whether the effects of CR in yeast are
dependent on the NAD dependant histone and protein deacetylase
Sir 2 is still controversial regarding the replicative ageing model
[100,102,103], but the fact that CR in yeast leads to lifespan extension
is not disclaimed. Respiration has been proposed to be an upstream
regulator of Sir 2 activity by affecting cellular NAD, NADH and nico-
tinamide levels [104,105].
Jiang et al. investigated on the interdependencies of nutritional
status and longevity in yeast. They found that yeast's replicative
lifespan is determined by glucose and amino acid concentrations, with
lower concentrations of both favouring longevity. Furthermore, they
conclude that in accordance to mammalian ageing, it is probably the
overall calorie consumption rather than a certain nutrient, which
accelerates ageing [106]. In contrary, Gomes et al. postulate that there
is a CR-independent, but TOR-regulated effect on lifespan regulation
through auxotrophy complementing amino acids [107]. Higher
concentrations of those amino acids seem to reduce oxidative stress
and thereby enhance chronological lifespan.
CR induced extension of yeast chronological lifespan has been
reported to be mediated through Ras and the nutrient responsive
kinases such as PKA, Sch9 (homologue of Akt/PKB) and TOR [108]
Reducing the activity of either of those four proteins resulted in
extension of yeast's chronological lifespan [28,109–111]. Ribosome
biogenesis, cell growth, stress responses and autophagy are regulated
downstream events controlled by these kinases [108,112] (Fig. 2).
The main branch of nutrient dependant signalling is made up by
the very well conserved Ser/Thr kinase TOR, whichwas initially found
as a target of rapamycin in S. cerevisiae, with its knock out conferring
resistance to rapamycin [113]. Although in S. cerevisiae two TOR genes
are found, higher eukaryotes only posses a single TOR gene. TOR is a
central controller of cell growth deploying its regulatory function
through the formation of two different multimeric TOR complexes
(TORC1/TORC2) [112]. TORC1 is sensitive to rapamycin and deter-
mines the time point “when” cells have to grow, whilst TORC2 action,
which is not inhibited by rapamycin, regulates “where” a cell grows by
controlling the actin cytoskeleton [112].
A recent study from Valter Longo's group demonstrated that
extracellular glycerol levels are increased in lifespan extending
mutants such as deletions of sch9, ras1 and tor1 [114]. Furthermore,
decreasing glycerol biosynthesis in these mutants reverts chronolog-
ical lifespan extension, thus, suggesting glycerol to be a crucial player
in longevity determination. Since glycerol does not affect CR effects, a
substitution of carbon sources in the diet by glycerol might represent
a serious alternative to CR.
It has been shown that autophagy is required for the lifespan
prolonging effects of CR in C. elegans [115]. Therefore, the increase of
Fig. 2. Nutrient responsive kinases and ageing. Nutrients such as glucose and amino acids stimulate the activity of the nutrient responsive kinases PKA, SCH9, and TOR. These, in turn
induce ribosome biogenesis, translation, nutrient import, and the actin organisation (not shown), or reduce autophagy and the stress response. Autophagy seems to have a major
role in the regulation of ageing and makes up an important branch for lifespan regulation through CR [119].
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event but still requires additional analysis in other model systems.
Switching on autophagic clearance, the cell reacts on energy deﬁciency
by recycling endogenous material, which is no longer needed. The
process can be regarded as “tidying up” the cell. A well-organized cell,
which only contains its essential components, is resultant at the end of
the process. Thereby, it eventually minimises the risk of organelles or
other cellular components to get out of control.With this theory periods
of starvation might contribute to the overall health of organisms.
Interestingly all human populations advice regular periods of fasting for
both religious and none religious reasons [116]. Thus, fasting may have
conferred a selective advantage over non-fasting populations. In a
spectacular experiment, it was demonstrated that in Drosophila even
the smelling of food might counteract the beneﬁt of CR (referred to as
dietary restriction in Drosophila). This olfactory regulation of lifespan is
evolutionarily conserved [117]. Postulating that this surprisingﬁnding is
valid in humans as well, it could be possible that the body prepares for
food uptake when smelling the odour of a meal. An easily detectable
effect is then the production of salivary liquid. But it is most likely that
the body even accommodates its biochemical markers, such as leptin
and ghrelin levels from the hypothalamus [118], anticipating that
energy will soon be available.6. Discussion: Human alimentation behaviour throughout
evolution — explanations for the disaster
A hypothesis how CR might have led to lifespan extension
throughout evolution was ﬁrst given by R. Holliday in 1989 [120].
He suggests that individuals that saved energy in times of restricted
resources might have better survived these hard periods, and were
therefore able to reproduce later on whilst others died or were no
longer able to reproduce.
One could also say that in response to CR animals extend their
lifespan in order to raise their chance of successful reproduction.
Since reproduction is very costly when seen from an energeticpoint of view, in times of CR fertility might be reduced due to that
reason.
Another explanation is to consider the process of ageing as
luxurious, which only highly nourished cells are able to perform. It is
only our human point of view making a long life more attractive but
regarded from the point of evolution, older individuals, which are still
capable to reproduce are a risk for the entire population to develop
genetic illness though being exposed to environmental stresses,
which may lead to DNA damage. When organisms suffer starvation
the process of ageing is eventually reduced due to not being essential
but costly. Famous musician Faron Young's rock'n'roll slogan “Live
fast, love hard, die young” makes sense in this context and seems to
have very natural roots within this scientiﬁc background: Eating and
begetting as the principle challenge of a human being no matter what
happens thereafter. Neil Young (not a relative) would say: “Better to
burn out than to fade away”.
With regard to early evolution of human life it is quite under-
standable that individuals who aimed on a high-calorie diet in times
of natural food restriction were preferred during evolutionary
selection. Nowadays, nutritional supply for humans is no longer
restricted, but human behaviour could not adapt – at least for agnostic
people – because of the evolutionary accommodation being much
more latent than the economical progress, which led to the quick
change in food supply. Therefore, the natural human instincts and
behaviours in combination with the recent food offer may have
caused such problems as obesity in our community. Regular fasting
may be a piece of human culture, which tames our nature and still
brings us back to (and mimics) an ancient point in evolution, where
nutrients were once scarce.
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